Hereditary spinocerebellar ataxia
ICD-10 G11.9 · ICD-11 8A03.1Z

Treatment of Hereditary Spinocerebellar Ataxia with Focal Spasticity in Small Muscles

Hereditary spinocerebellar ataxia can present with focal spasticity, particularly affecting small muscles. This specific clinical picture calls for a targeted, evidence-based management approach distinct from general ataxia care.

Clinical scenario: Focal spasticity — especially in small muscle groups — is a recognised complication in hereditary spinocerebellar ataxia and is supported by evidence from numerous well-controlled, randomised trials as a treatable target.

Approach

Management involves referral to a specialised clinic for a targeted intramuscular intervention. The complete regimen — including the subsequent rehabilitation component and all clinical steps — is set out in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

Focal spasticity, particularly in small muscles, is probably best treated with intramuscular botulinum toxin injections for which numerous well-controlled, randomized trials have shown benefit.

To treat focal spasticity, particularly in small muscles, refer to a specialised clinic for treatment with intramuscular botulinum toxin injections, followed by physiotherapy.

View source ↗